Last reviewed · How we verify
Budesonide respules
At a glance
| Generic name | Budesonide respules |
|---|---|
| Also known as | Pulmicort respules |
| Sponsor | Phoenix Children's Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Pulmicort Respules on Relapse Rates After Treatment in the ED (PHASE4)
- ARrest RESpiraTory Failure From PNEUMONIA (PHASE3)
- Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19) (PHASE4)
- The Effect of Modified Olfactory Training on Postoperative Olfactory Dysfunction in Patients With CRS (NA)
- Continuous Versus Intermittent Nebulization Therapy in Acute Asthma Exacerbation at Emergency Department (NA)
- Single-dose AQ001S PK Study in Healthy Volunteers (PHASE1)
- The Role of Budesonide Intrapolyp Injection in CRSwNP (PHASE4)
- Inhaled Steroids for the Treatment of Early Pediatric Acute Respiratory Distress Syndrome (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |